Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 249 of the 262 references it cites were found in a registry or an index.

Cannabinoid receptors and pain

Pertwee, Roger G. · 2001 · Progress in Neurobiology

Abstract

Mammalian tissues contain at least two types of cannabinoid receptor, CB(1) and CB(2), both coupled to G proteins. CB(1) receptors are expressed mainly by neurones of the central and peripheral nervous system whereas CB(2) receptors occur centrally and peripherally in certain non-neuronal tissues, particularly in immune cells. The existence of endogenous ligands for cannabinoid receptors has also been demonstrated. The discovery of this 'endocannabinoid system' has prompted the development of a range of novel cannabinoid receptor agonists and antagonists, including several that show marked selectivity for CB(1) or CB(2) receptors. It has also been paralleled by a renewed interest in cannabinoid-induced antinociception. This review summarizes current knowledge about the ability of cannabinoids to produce antinociception in animal models of acute pain as well as about the ability of these drugs to suppress signs of tonic pain induced in animals by nerve damage or by the injection of an inflammatory agent. Particular attention is paid to the types of pain against which cannabinoids may be effective, the distribution pattern of cannabinoid receptors in central and peripheral pain pathways and the part that these receptors play in cannabinoid-induced antinociception. The possibility that antinociception can be mediated by cannabinoid receptors other than CB(1) and CB(2) receptors, for example CB(2)-like receptors, is also discussed as is the evidence firstly that one endogenous cannabinoid, anandamide, produces antinociception through mechanisms that differ from those of other types of cannabinoid, for example by acting on vanilloid receptors, and secondly that the endocannabinoid system has physiological and/or pathophysiological roles in the modulation of pain.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0301-0082(00)00031-9

Cites

249 of 249 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 262 references

Research works printed but not linked: 9

  1. Bhattacharya, 1989, Role of prostaglandins in some neuropharmacological actions of delta-9-tetrahydrocannabinol (THC) in the rat, Asia Pacific J. Pharmacol., 4, 179
  2. Breivogel, C.S., Walker, J.M., Huang, S., Childers, S.R., 1999. Cannabinoid signalling in cultured rat cerebellar granule cells. International Cannabinoid Research Society 1999, Symposium on the Cannabinoids, Burlington, Vermont, p. 19.
  3. Cowan, A., Pars, H.G., Razdan, R.K., Harris, L.S., Dewey, W.L., Essigmann, E.M., 1985. Antinociceptive activity of menabitan. In: Harvey, D.J. (Ed.), Marijuana '84, IRL Press, Oxford, pp. 693–699.
  4. Finnegan-Ling, D., Musty, R.E., 1994. Marinol and phantom limb pain: a case study, Proc. Int. Cannabinoid. Res. Soc., p. 53.
  5. Kathmann, M., Nakazi, M., Bauer, U., Schlicker, E., 1999b. WIN 55212-2 inhibits serotonin release in the mouse brain cortex via presynaptic cannabinoid CB1 receptors. International Cannabinoid Research Society 1999, Symposium on the Cannabinoids, Burlington, Vermont, p. 51.
  6. Kaymakcalan, 1972, Some pharmacologic properties of synthetic Δ9-tetrahydrocannabinol (THC), Acta Med. Turcica, Suppl. 1, 5
  7. Kearn, C.S., Hillard, C.J., 1999. A model for the study of cannabinoid actions in microglia. International Cannabinoid Research Society 1999, Symposium on the Cannabinoids, Burlington, Vermont, p. 44.
  8. Martin, B.R., 1985a. Characterization of the antinociceptive activity of intravenously administered delta-9-tetrahydrocannabinol in mice. In: Harvey, D.J. (Ed.), Marihuana ‘84 IRL Press, Oxford, pp. 685–692.
  9. Ross, 1999, Evidence for cannabinoid receptor-mediated inhibition of voltage-activated Ca2+ currents in neonatal rat cultured DRG neurones, Br. J. Pharmacol., 128, 13P

Cited by

See all 856

Metadata

Authors
Pertwee, R. G.
Affiliations
University of Aberdeen (GB)
Corresponding author
Pertwee, Roger G.
Venue
Progress in Neurobiology
Publisher
Elsevier BV
Published
2001-04
Volume
63
Issue
5
Pages
569-611
ISSN
0301-0082 (ISSN-L)
OpenAlex
W1982186440
Cited by
741
References
262
Citations by year
2026: 5 · 2025: 9 · 2024: 21 · 2023: 19 · 2022: 19 · 2021: 18 · 2020: 28 · 2019: 24 · 2018: 21 · 2017: 25 · 2016: 14 · 2015: 21 · 2014: 33 · 2013: 30 · 2012: 36
FWCI
5.60
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Progress in Neurobiology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
  • Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
  • Life Sciences › Neuroscience › Sensory Systems › Ion Channels and Receptors
Keywords
cannabinoid receptors, CB1 receptor, CB2 receptor, endocannabinoid system, antinociception, pain, acute pain, neuropathic pain, inflammatory pain, anandamide, vanilloid receptor, cannabinoid receptor agonists, cannabinoid receptor antagonists, G protein-coupled receptors, pain modulation
MeSH terms
Acute Disease, Analgesics, Animals, Haplorhini, Brain, Cannabinoids, Chronic Disease, Disease Models, Animal, Humans, Ligands, Pain, Pain Measurement, Receptors, Drug, Spinal Cord, Receptors, Cannabinoid, Receptor, Cannabinoid, CB2, Mice, Rats, Cannabinoid Receptor Modulators

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cannabinoid receptors and pain. https://app.cochat.ai/papers/10.1016/s0301-0082(00)00031-9
The paper
Pertwee, R. G. (2001). Cannabinoid receptors and pain. Progress in Neurobiology. https://doi.org/10.1016/s0301-0082(00)00031-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.